| Name | Title | Contact Details |
|---|
Amico Corporation is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Warner Tech-Care Products is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospicelink has created a nationally recognized , award winning software solution, specifically focused on the unique relationship between Hospice Companies and DME Providers. Although the needs of each Company can be vastly different, we understand the pressures in today`s marketplace and the difficulties these create for the industry. Hospicelink has addressed the challenges of providing optimal care while maintaining compliance and improving operational efficiencies, enabling your staff to balance multiple responsibilities. Hospicelink has a proven track record of helping clients solve these problems through our comprehensive set of innovative solutions. Our state-of-the-art application assists Hospice Companies and DME Providers with the ordering, billing, reporting and contract management processes. Hospicelink`s Executive Dashboard provides access to real-time actionable data, allowing a proactive response and improvement of identified inefficiencies.
At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.
A-Med Home Health is a Texas City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.